Free Trial

Christopher Marinac Analyst Performance

Analyst at Janney Montgomery Scott

Christopher Marinac is a stock analyst at Janney Montgomery Scott, covering 10 publicly traded companies across a range of sectors. Over the past year, Christopher Marinac has issued 4 stock ratings, including buy and hold recommendations. While full access to Christopher Marinac's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Christopher Marinac's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
10 Last 8 Years
Buy Recommendations
50.00% 5 Buy Ratings
Companies Covered
10 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy50.0%5 ratings
Hold50.0%5 ratings
Sell0.0%0 ratings

Out of 10 total stock ratings issued by Christopher Marinac at Janney Montgomery Scott, the majority (50.0%) have been Buy recommendations, followed by 50.0% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
80.0% of companies on NASDAQ
8 companies
NYSE
20.0% of companies on NYSE
2 companies

Christopher Marinac, an analyst at Janney Montgomery Scott, currently covers 10 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Finance
8 companies
80.0%
Computer and Technology
1 company
10.0%
Medical
1 company
10.0%

Christopher Marinac of Janney Montgomery Scott specializes in stock coverage within the Finance sector, with additional focus on Computer and Technology and Medical companies.

Coverage Industries

IndustryPercentage
BANKS - SOUTHEAST
3 companies
30.0%
FIN - SVGS & LOAN
2 companies
20.0%
BANKS - NORTHEAST
1 company
10.0%
MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT, & SUPPLIES
1 company
10.0%
MED - BIOMED/GENE
1 company
10.0%
STATE COMMERCIAL BANKS
1 company
10.0%
NATIONAL COMMERCIAL BANKS
1 company
10.0%

Christopher Marinac's Ratings History at Janney Montgomery Scott

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Northpointe Bancshares, Inc. stock logo
NPB
Northpointe Bancshares
8/28/2025Initiated Coverage$17.75$19.25Neutral
Eagle Bancorp, Inc. stock logo
EGBN
Eagle Bancorp
6/10/2025Upgrade$17.68$24.00Buy
First Bancorp stock logo
FBNC
First Bancorp
2/7/2025Downgrade$45.94Neutral
Trustmark Corporation stock logo
TRMK
Trustmark
1/24/2025Initiated Coverage$35.02$42.00Buy